{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:45:26Z","timestamp":1767134726876,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd005165","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2007,1,24]],"date-time":"2007-01-24T00:00:00Z","timestamp":1169596800000}}],"reference-count":73,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005165.pub2","type":"journal-article","created":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T14:25:39Z","timestamp":1170771939000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Probiotics for non-alcoholic fatty liver disease and\/or steatohepatitis"],"prefix":"10.1002","volume":"2010","author":[{"given":"Flavio","family":"Lirussi","sequence":"first","affiliation":[{"name":"WHO Regional Office for Europe, European Office for Investment for Health and Development; Scientist, Socioeconomic Determinants of NCDs; Campo Santo Stefano, San Marco 2847 Venice Italy I-30124"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezio","family":"Mastropasqua","sequence":"additional","affiliation":[{"name":"Ospedale di Este; Via S Fermo Padova Italy 35042 Este"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Orando","sequence":"additional","affiliation":[{"name":"Universit\u00e1 Degli Studi di Firenze; Instituto di Anestesia e Rianimazione; Azienda Ospedaliero-Universitaria di Careggi Viale della Maternit\u00e1 Firenze Italy 50134"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco","family":"Orlando","sequence":"additional","affiliation":[{"name":"University of Padua Medical School; Department of Medical and Surgical Sciences; via Giustiani, 2 Padova Italy 35128"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,1,24]]},"reference":[{"key":"10.1002\/14651858.CD005165.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1572-0241.2002.05942.x","article-title":"Gut-liver axis: a new point of attack to treat chronic liver damage?","volume":"97","author":"Loguercio","year":"2002","journal-title":"American Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD005165.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.mcg.0000165671.25272.0f","article-title":"Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases","volume":"39","author":"Loguercio","year":"2005","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD005165.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/hep.510300604","article-title":"Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"16","author":"Angulo","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD005165.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.dld.2004.01.012","article-title":"Searching for coeliac disease in patients with non-alcoholic fatty liver disease","volume":"36","author":"Bardella","year":"2004","journal-title":"Digestive and Liver Diseases"},{"issue":"5","key":"10.1002\/14651858.CD005165.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/hep.510230513","article-title":"Prediction of risk of liver disease by alcohol intake, sex and age: a prospective population study","volume":"23","author":"Becker","year":"1996","journal-title":"Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD005165.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archsurg.133.1.84","article-title":"Unsuspected cirrhosis discovered during obesity operations","volume":"133","author":"Brolin","year":"1998","journal-title":"Archives of Surgery"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2001-12925","article-title":"Nonalcoholic steatohepatitis: definition and pathology","volume":"21","author":"Brunt","year":"2001","journal-title":"Seminars in Liver Diseases"},{"issue":"4","key":"10.1002\/14651858.CD005165.pub2-BIB0010|cit10","first-page":"246","article-title":"Diagnosis and interpretation of steatosis and steatohepatitis","volume":"15","author":"Burt","year":"1998","journal-title":"Seminars in Diagnostic Pathology"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.510290347","article-title":"Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease","volume":"29","author":"Calwell","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2001-12927","article-title":"Etiopathogenesis of non-alcoholic steatohepatitis","volume":"21","author":"Chitturi","year":"2001","journal-title":"Seminars in Liver Diseases"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/jhep.2002.30692","article-title":"NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome","volume":"35","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0014|cit14","first-page":"S5","article-title":"The epidemiology of nonalcoholic fatty liver disease in adults","volume":"40 Suppl 1","author":"Clark","year":"2006","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD005165.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1053\/gast.2000.19267","article-title":"Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis","volume":"119","author":"Cope","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0016|cit16","first-page":"387","article-title":"Prevalence of gastrointestinal symptoms in obese and normal weight binge eaters","volume":"89","author":"Crowell","year":"1994","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD005165.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7861\/clinmedicine.6-1-19","article-title":"Non-alcoholic fatty liver disease: current concepts and management strategies","volume":"6","author":"Day","year":"2006","journal-title":"Clinical Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005165.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods for combining randomized clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005165.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0020|cit20","first-page":"160","article-title":"Cytokine regulation of liver injury and repair","volume":"174","author":"Diehl","year":"2000","journal-title":"Immunology"},{"issue":"1","key":"10.1002\/14651858.CD005165.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2001.25540","article-title":"Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese","volume":"121","author":"Dixon","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0016-5085(82)80403-4","article-title":"Hepatic steatosis after intestinal bypass. Prevention and reversal by metronidazole, irrespective of protein calorie malnutrition","volume":"82","author":"Drenick","year":"1982","journal-title":"Gastroenterology"},{"issue":"7109","key":"10.1002\/14651858.CD005165.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005165.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000051918","article-title":"Helicobacter pylori infection increases mucosal permeability of the stomach and intestine","volume":"63","author":"Fukuda","year":"2001","journal-title":"Digestion"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/gut.2003.034249","article-title":"Probiotics in inflammatory bowel disease: is it all gut flora modulation?","volume":"53","author":"Ghosh","year":"2004","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD005165.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1053\/gast.2000.9370","article-title":"Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial","volume":"119","author":"Gionchetti","year":"2000","journal-title":"Gatroenterology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005165.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1590-8658(02)80166-9","article-title":"Probiotics - role in inflammatory bowel disease","volume":"34","author":"Gionchetti","year":"2002","journal-title":"Digestive and Liver Diseases"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0028|cit28","first-page":"322","article-title":"Alcoholic hepatitis: no glucocorticosteroids?","volume-title":"Steatohepatitis (NASH and ASH), Falk Symposium 121","author":"Gluud","year":"2001"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0029|cit29","unstructured":"Gluud C Als-Nielsen B D'Amico G Fingerhut A Gluud LL Khan S Hepato-Biliary Group About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2006, Issue 3. Art. No.: LIVER"},{"issue":"1","key":"10.1002\/14651858.CD005165.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2036.2001.00898.x","article-title":"Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans","volume":"15","author":"Gotteland","year":"2001","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD005165.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/gut.49.4.596","article-title":"Is coeliac disease a confounding factor in the diagnosis of NASH?","volume":"49","author":"Grieco","year":"2001","journal-title":"Gut"},{"issue":"3","key":"10.1002\/14651858.CD005165.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"F186","DOI":"10.1136\/fn.83.3.F186","article-title":"Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0-6 months","volume":"83","author":"Gronlund","year":"2000","journal-title":"Archives of Disease in Childhood, Fetal and Neonatal Edition"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00005176-200001000-00018","article-title":"Lactobacillus GG administered in oral rehydration solution to children with acute diarrhoea: a multicenter European trial","volume":"30","author":"Guandalini","year":"2000","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD005165.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0924-8579(03)00153-5","article-title":"The role of probiotics in the treatment and prevention of Helicobacter pylori infection","volume":"22","author":"Hamilton-Miller","year":"2003","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"9","key":"10.1002\/14651858.CD005165.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1111\/j.1572-0241.2003.07659.x","article-title":"The natural history of nonalcoholic fatty liver disease: a clinical histopathological study","volume":"98","author":"Harrison","year":"2003","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifyng heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0037|cit37","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006] The Cochrane Library, Issue 4, 2006 Chichester, UK John Wiley & sons, Ltd"},{"issue":"319","key":"10.1002\/14651858.CD005165.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised trials","volume":"11","author":"Hollis","year":"1999","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1126\/science.291.5505.881","article-title":"Molecular analysis of commensal host-microbial relationships in the intestine","volume":"291","author":"Hooper","year":"2001","journal-title":"Science"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/13590849009003132","article-title":"Gut fermentation (or auto-brewery) syndrome. A new clinical test with initial observations and discussion of clinical and biological implications","volume":"1","author":"Hunnisett","year":"1990","journal-title":"Journal of Nutritional & Environmental Medicine"},{"issue":"12","key":"10.1002\/14651858.CD005165.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1080\/003655200453601","article-title":"Probiotic therapy fails to imoprove gut permeability in a hapten model of colitis","volume":"35","author":"Kennedy","year":"2000","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD005165.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005165.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1055\/s-2001-12932","article-title":"Animal models of steatosis","volume":"21","author":"Koteish","year":"2001","journal-title":"Seminars in Liver Diseases"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1128\/AEM.66.9.3692-3697.2000","article-title":"Quantitative approach in the study of adhesion of lactic acid bacteria on intestinal cells and their competition with enterobacteria","volume":"66","author":"Lee","year":"2000","journal-title":"Applied and Environmental Microbiology"},{"issue":"2","key":"10.1002\/14651858.CD005165.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/jhep.2003.50048","article-title":"Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease","volume":"37","author":"Li","year":"2003","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD005165.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0016-5085(91)90224-9","article-title":"Hepatic injury associated with small intestinal bacterial overgrowth in rats is prevented by metronidazole and tetracycline","volume":"100","author":"Lichtman","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0047|cit47","first-page":"S11","article-title":"Natural history of nonalcoholic steatohepatitis","volume":"40, Suppl 1","author":"Liou","year":"2006","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0048|cit48","doi-asserted-by":"crossref","unstructured":"Lirussi F Mastropasqua E Orando S Orlando R Probiotics for non-alcoholic fatty liver disease and\/or steatohepatitis (Protocol) Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD005165. DOI: 10.1002\/14651858.CD005165","DOI":"10.1002\/14651858.CD005165"},{"issue":"2","key":"10.1002\/14651858.CD005165.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000016909","article-title":"Fatty liver and nonalcoholic steatohepatitis. Where we stand and where are we going?","volume":"17","author":"Lonardo","year":"1999","journal-title":"Digestive Diseases"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/sim.698","article-title":"A comparison of methods to detect publication bias in meta-analysis","volume":"20","author":"Macaskill","year":"2001","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005165.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1053\/gast.2001.27224","article-title":"Probiotics bacteria enhance murine and human intestinal epithelial barrier function","volume":"121","author":"Madsen","year":"2001","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD005165.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1023\/A:1017947531536","article-title":"Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability","volume":"47","author":"Mangell","year":"2002","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0053|cit53","first-page":"S17","article-title":"Pathophysiology of nonalcoholic steatohepatitis","volume":"40 Suppl 1","author":"McCullogh","year":"2006","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD005165.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00004836-200203000-00013","article-title":"Update on nonalcoholic fatty liver disease","volume":"34","author":"McCullough","year":"2002","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.2337\/diacare.27.8.2057","article-title":"Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis","volume":"27","author":"Medina","year":"2004","journal-title":"Diabetes Care"},{"issue":"9128","key":"10.1002\/14651858.CD005165.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0057|cit57","first-page":"349","article-title":"Non-alcoholic steatohepatitis associated with small intestinal diverticulosis and bacterial overgrowth","volume":"36","author":"Nazim","year":"1989","journal-title":"Hepato-gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD005165.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD single topic conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD005165.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0022-4804(91)90078-Z","article-title":"Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat","volume":"51","author":"Pappo","year":"1991","journal-title":"Journal of Surgical Research"},{"issue":"6","key":"10.1002\/14651858.CD005165.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/0148607192016006529","article-title":"Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide","volume":"16","author":"Pappo","year":"1992","journal-title":"Journal of Parenteral and Enteral Nutrition"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1053\/jhep.2000.17894","article-title":"Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study","volume":"32","author":"Poonawala","year":"2000","journal-title":"Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD005165.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0016-5085(00)70364-7","article-title":"Liver fibrosis in overweight patients","volume":"118","author":"Ratziu","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/gut.52.7.988","article-title":"Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC)","volume":"52","author":"Resta-Lenert","year":"2003","journal-title":"Gut"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0064|cit64","unstructured":"Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2003"},{"issue":"1","key":"10.1002\/14651858.CD005165.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/gut.50.1.136-a","article-title":"Small intestinal bacterial overgrowth, intestinal permeability, and non-alcoholic steatohepatitis","volume":"50","author":"Riordan","year":"2002","journal-title":"Gut"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005165.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1079\/BJN19980108","article-title":"Functional food science and gastrointstinal physiology and function","volume":"80","author":"Salminen","year":"1998","journal-title":"British Journal of Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD005165.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"Journal of the American Medical Association"},{"issue":"5","key":"10.1002\/14651858.CD005165.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0168-8278(03)00097-7","article-title":"Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics","volume":"38","author":"Solga","year":"2003","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD005165.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s10620-005-2720-8","article-title":"Increased orocecal transit time in patients with nonalcoholic fatty liver disease","volume":"50","author":"Soza","year":"2005","journal-title":"Digestive Disease and Science"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1053\/gast.2002.31065","article-title":"Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease","volume":"122","author":"Valenti","year":"2002","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD005165.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1046\/j.1365-2036.1999.00560.x","article-title":"Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis","volume":"13","author":"Venturi","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD005165.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.48.2.206","article-title":"The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxemia, and TNF alpha in the pathogenesis of non-alcoholic steatohepatitis","volume":"48","author":"Wigg","year":"2001","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD005165.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1053\/jhep.2002.32483","article-title":"Nonalcoholic fatty liver disease: an agenda for clinical research","volume":"35","author":"Younossi","year":"2002","journal-title":"Hepatology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005165.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T18:02:37Z","timestamp":1645639357000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005165.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2007,1,24]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005165.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,24]]}}}